Jenna L. Koliani‐Pace

Author

Also Known As

J L Koliani-Pace, J.L. Koliani-Pace, Jenna Koliani-Pace, Jenna L Koliani-Pace, Jenna L. Koliani-Pace, Jenna L. Koliani‐Pace

Publications

906

Citations

H-Index

Concepts

All Affiliations

Dartmouth–Hitchcock Medical Center Cleveland Clinic University of California San Diego Indiana University – Purdue University Indianapolis Lenox Hill Hospital

About

Jenna L. Koliani‐Pace is an author at Dartmouth–Hitchcock Medical Center specializing in gastroenterology, medicine, and addiction medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Gastroenterology	2	2	44
2	Health Sciences	1	1	30
3	Medicine	1	1	14
4	Inflammation	1	1	14
5	Pain Management	1	1	30

Jenna L. Koliani‐Pace

Publications

765

Citations

H-Index

Page 1

	Year	Citations
Open: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium Neeraj Narula, Farhad Peerani, Joseph Meserve, The American Journal of Gastroenterology	2018	171
Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn’s Disease Parambir S. Dulai, Brigid S. Boland, Siddharth Singh, Gastroenterology	2018	140
Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases Joseph Meserve, Satimai Aniwan, Jenna L. Koliani‐Pace, Clinical Gastroenterology and Hepatology	2018	81
Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis Parambir S. Dulai, Siddharth Singh, Niels Vande Casteele, Clinical Gastroenterology and Hepatology	2020	76
Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease Eugenia Shmidt, Gursimran Kochhar, Justin Hartke, Inflammatory Bowel Diseases	2018	74
Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn’s Disease But Not Ulcerative Colitis David M. Faleck, Adam C. Winters, Shreya Chablaney, Clinical Gastroenterology and Hepatology	2019	67
Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis Dana J. Lukin, David M. Faleck, Ronghui Xu, Clinical Gastroenterology and Hepatology	2020	58
Effects of Medical Cannabis on Use of Opioids and Hospital Visits by Patients With Painful Chronic Pancreatitis Trevor Barlowe, Jenna L. Koliani‐Pace, Kerrington D. Smith, Clinical Gastroenterology and Hepatology Cannabis UseMedical CannabisHealth SciencesPancreatic Fluid CollectionAddiction	2019	30
Patients’ Perceive Biologics to Be Riskier and More Dreadful Than Other IBD Medications Jenna L. Koliani‐Pace, Anna M Haron, Yaara Zisman‐Ilani, Inflammatory Bowel Diseases	2019	16
Changes in Vedolizumab Utilization Across US Academic Centers and Community Practice Are Associated With Improved Effectiveness and Disease Outcomes Jenna L. Koliani‐Pace, Siddharth Singh, Michelle Luo, Inflammatory Bowel Diseases	2019	15

Page 1